Medicine Research.CRO provides drug research, clinical trial, testing and regulatory services to pharmaceutical and healthcare clients.
Founded in 2018 and based in Beijing, China, Medicine Research.CRO provides contract research services for pharmaceutical development. Its work includes drug research, clinical trial support, biobank testing, registration consultation and Market Authorization Holder services. Clients include pharmaceutical companies, biotech firms and research institutions. In March 2025, it raised an undisclosed amount in Series A+ funding from Sinar Mas and Zijin Venture Capital Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in